DocG DocG | AI-Powered Clinical Summaries
← DocG Medical Summaries

Top Gastroenterology Research Papers

Live ranking — trailing 6 months, each paper's latest score Scores fold Gastroenterology Relevance & Applicability into the quality dimensions; papers scored before the dynamic-specialty rubric keep their original score Showing the top 10 of 267 ranked articles — sign in free for the full ranking and per-criterion score breakdowns
1. 7.2
Fiber Supplementation in Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Overall: This registered meta-analysis finds a clinically meaningful but modest improvement in IBS response with readily implementable fiber supplementation, although incomplete safety, heterogeneity, subtype, and outcome-definition information limits certainty and practice-changing impact.
2. 7.2
Holding vs Continuing GLP-1/GIP Agonists Before Upper Endoscopy: The OCULUS Randomized Clinical Trial.
Overall: Holding one GLP-1 or GLP-1/GIP agonist dose substantially reduced clinically significant retained gastric contents, but the small early-terminated trial and absence of increased adverse events limit definitive practice-changing conclusions.
3. 7.2
Vonoprazan-Tetracycline Dual Regimen as Rescue Therapy for Helicobacter pylori Infection: Randomized Controlled Trial.
Overall: This randomized trial found comparable eradication with substantially fewer adverse effects and better adherence, making the dual regimen promising despite uncertain transferability to US rescue-treatment practice.
4. 7.0
Prognostic Performance of Liver Stiffness Measurements in Primary Sclerosing Cholangitis: The Prospective FICUS cohort.
Overall: This well-conducted prospective cohort establishes clinically meaningful prognostic associations for an accessible noninvasive test, but it does not demonstrate that acting on those results improves outcomes.
5. 7.0
Fecal Occult Blood Screening Outcomes Adjusted for Contamination Bias and Nonadherence.
Overall: This large prospective registry-based study links FOBT screening with lower colorectal cancer mortality, but modeled bias adjustments, absent absolute effects and harms, and confirmation of an established practice limit its impact.
6. 6.9
In-person therapist-delivered hypnotherapy versus smartphone-based self-guided hypnotherapy in IBS: a multicentre three-armed randomised controlled trial.
Overall: This clinically relevant randomized trial supports hypnotherapy for IBS and suggests promise for a scalable smartphone option, although the failed noninferiority result and incomplete reporting of harms and trial safeguards limit immediate practice change.
7. 6.8
Direct Oral Anticoagulants, COX-2-Selective NSAIDs, and Gastrointestinal Bleeding in Atrial Fibrillation.
Overall: This large observational study provides clinically useful evidence favoring COX-2-selective NSAIDs during DOAC therapy, but absent absolute effects and unmeasured cardiovascular outcomes temper confidence.
8. 6.8
Glucagon-like peptide-1 receptor agonists and pancreatic outcomes in chronic pancreatitis: a real-world cohort study.
Overall: This large US observational study reports substantial improvements in important clinical outcomes, but residual confounding limits causal interpretation and immediate practice change.
9. 6.8
Chemoradiotherapy versus short-course radiotherapy for response-adapted organ preservation in early-stage and intermediate-stage rectal cancer (STAR-TREC): 12-month results of an international, multicentre, open-label, parallel-group, randomised, phase 2/3 trial.
Overall: This randomized multicentre trial shows a substantial early organ-preservation advantage for LCCRT, but definitive functional and oncological outcomes require longer follow-up.
10. 6.8
The Comparative Effectiveness of Carvedilol Versus Other Nonselective β-Blockers in Cirrhosis.
Overall: This well-adjusted US observational comparison suggests a moderate reduction in serious cirrhosis complications with carvedilol, but residual confounding, unreported harms, and the specialist-heavy context limit its ability to change primary care practice independently.
Score Guide: 9-10 Exceptional 7-8 Strong 5-6 Moderate 3-4 Weak 1-2 Poor

Get the top Gastroenterology papers in your inbox

Free 300-word clinical summaries 3× per week, plus the full ranking of all 267 recent Gastroenterology papers with per-criterion AI score breakdowns.

Sign Up Free